Navigation Links
DNA2.0 Patents Key Method for Synthesizing Bioplastic Polymer

Menlo Park, CA (PRWEB) June 29, 2012

DNA2.0 announced that the USPTO has recognized its bioengineering work by awarding the company a new patent. Patent 8,158,391 covers genetic modifications to yeast of the genus Candida that enable them to produce commercially valuable yields of omega hydroxy fatty acids. Until now, these key chemical building blocks could only be produced using synthetic chemistry, making them too expensive for most applications. DNA2.0 expects this new bio-based production route to make hydroxy fatty acids available for the synthesis of lubricants, adhesives and monomers for a unique family of bio-based plastics. Unlike existing bioplastics, this new polymer will have properties very similar to polyethylene, allowing for easy acceptance in the marketplace. The plastics can be used for packaging and other purposes and can afterwards be broken down and turned into diesel fuel.

DNA2.0 collaborated with Professor Richard Gross and his lab at Polytechnic University in Brooklyn, N.Y. to engineer the yeast. The yeast production strain was engineered to produce omega hydroxy fatty acids by identifying and eliminating from the yeast genome 16 genes that had been preventing accumulation of the desired compounds. DNA2.0 then introduced genes encoding different hydroxylation enzymes, allowing Professor Gross' lab to identify those that best produced hydroxyl fatty acids.

“This patent demonstrates the value of DNA2.0’s tools, which have enabled a small team of scientists to rewire a cell for cost-effective production of useful chemicals,” said Jeremy Minshull, cofounder and CEO of DNA2.0. “Weaning ourselves from petrochemicals will require us to develop renewable alternatives without compromising performance. We are proud to leverage our engineering expertise to co-develop solutions with pioneering scientists such as Professor Gross.”

The research to develop the patent was funded in part by a Defense Advanced Research Projects Agency (DARPA) grant for its Mobile Integrated Sustainable Energy Recovery (MISER) program. The goal is to achieve nearly complete plastic packaging waste reduction while harnessing 90 percent of the packaging energy content for use in electricity generation.

About DNA2.0
DNA2.0 is the leading bioengineering solutions provider. Founded in 2003, DNA2.0 offers an integrated pipeline of solutions for the research community, including gene design, optimization, synthesis and cloning, as well as platforms for protein and strain engineering. It is the fastest provider of synthetic genes—based in the US with a global customer base encompassing academia, government and the pharmaceutical, chemical, agricultural and biotechnology industries. DNA2.0 is by far the most published synthetic gene vendor, providing expert support to and collaboration with scientists. DNA2.0 explores novel applications for synthetic genes and is exploiting the synergy between highly efficient gene design and synthesis processes and new protein optimization technologies. DNA2.0’s tools and solutions are fueling the transformation of biology from a discovery science to an engineering discipline. The company is privately held and is headquartered in Menlo Park, Calif. For more information, please visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Silence Therapeutics Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents
2. NanoLogix Instructs Third-Party to Prepare US FDA Submittals and is Granted US and Chinese Patents
3. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
4. New method for producing precursor of neurons, bone and other important tissues from stem cells
5. UCLA team develops highly efficient method for creating flexible, transparent electrodes
6. New method for enhancing thermal conductivity could cool computer chips, lasers and other devices
7. New laboratory method uses mass spectrometry to rapidly detect staph infections
8. Novel method to make nanomaterials discovered
9. Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria
10. New method yields insulin-producing pancreatic cell clusters
11. X-BODY BioSciences to Present Novel Methods of Selecting for Antibodies Against Targets on Live Cells at CHIs Protein Engineering Summit
Post Your Comments:
(Date:6/23/2016)... June 23, 2016 Houston Methodist Willowbrook ... Cy-Fair Sports Association to serve as their official ... Houston Methodist Willowbrook will provide sponsorship support, athletic ... with association coaches, volunteers, athletes and families. ... Cy-Fair Sports Association and to bring Houston Methodist ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the Pennsylvania Convention Center and will showcase its product’s latest features from June ... be presenting a scientific poster on Disrupting Clinical Trials in The Cloud during ...
Breaking Biology Technology:
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
Breaking Biology News(10 mins):